Bioprocessing 4.0 refers to the next evolution of biologics manufacturing that moves to a single processing environment, leveraging advanced digital and process technologies to increase connectivity, computing power and intelligence. The resulting controlled manufacturing processes maximize facility uptime while minimizing human intervention. Merrilee Whitney, Head of our BioContinuum™ Platform, discusses how we’ve been a key driver of this evolution, bringing Bioprocessing 4.0 to the here and now.

свернуть